Radiation Necrosis clinical trials

Explore recruiting radiation necrosis clinical trials.

Recruiting radiation necrosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Radiation Necrosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Bevacizumab for the treatment of cerebral RAdiation Induced NecrosiS (BRAINS) study: A multicenter, open-label, randomized clinical trial to assess the clinical efficacy and cost-effectiveness of bevacizumab versus corticosteroids as first-line treatment in patients with symptomatic cerebral radiation necrosis after radiation for high grade glioma or brain metastases

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Radiation Necrosis trials by city

Radiation Necrosis in Toronto Radiation Necrosis in Vancouver Radiation Necrosis in Montreal Radiation Necrosis in Calgary Radiation Necrosis in Edmonton Radiation Necrosis in Ottawa Radiation Necrosis in Winnipeg Radiation Necrosis in Quebec City Radiation Necrosis in Hamilton Radiation Necrosis in Kitchener Radiation Necrosis in London Radiation Necrosis in Halifax Radiation Necrosis in New York Radiation Necrosis in Los Angeles Radiation Necrosis in Chicago Radiation Necrosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease